tiprankstipranks
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market
PPLPHARMA
Piramal Pharma Limited
RESEARCH TOOLSreports
Want to see IN:PPLPHARMA full AI Analyst Report?

Piramal Pharma Limited (PPLPHARMA) Income Statement

12 Followers

Piramal Pharma Limited Income Statement

Last quarter (Q2 2026), Piramal Pharma Limited's total revenue was ₹20.44B, a decrease of -8.83% from the same quarter last year. In Q2, Piramal Pharma Limited's net income was ₹-992.20M. See Piramal Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
₹ 88.69B₹ 90.61B₹ 81.06B₹ 70.32B₹ 64.72B
Gross Profit
₹ 23.83B₹ 54.89B₹ 48.48B₹ 40.32B₹ 37.91B
Operating Expenses
₹ 22.93B₹ 48.10B₹ 43.86B₹ 40.80B₹ 34.26B
Depreciation and Amortization
₹ 8.31B₹ 8.16B₹ 7.41B₹ 6.77B₹ 5.86B
EBITDA
₹ 9.22B₹ 16.49B₹ 13.67B₹ 8.94B₹ 12.60B
Operating Income
₹ 903.80M₹ 6.79B₹ 4.62B₹ -479.70M₹ 3.65B
Other Income/Expenses
₹ -2.66B₹ -2.64B₹ -2.83B₹ -721.80M₹ 1.20B
Pretax Income
₹ -1.76B₹ 4.15B₹ 1.79B₹ -1.20B₹ 4.85B
Net Income
₹ -3.26B₹ 911.30M₹ 178.20M₹ -1.86B₹ 3.76B
Per Share Metrics
Basic EPS
₹ -2.46₹ 0.69₹ 0.14₹ -1.54₹ 3.09
Diluted EPS
₹ -2.46₹ 0.68₹ 0.14₹ -1.54₹ 3.09
Weighted Average Shares Outstanding
 1.32B 1.34B 1.27B 1.21B 1.22B
Weighted Average Shares Outstanding (Diluted)
 1.32B 1.34B 1.28B 1.21B 1.22B
Currency in INR

Piramal Pharma Limited Earnings and Revenue History